ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Effectiveness and Limitations of PK Analysis in Optimization of Immunosuppressive Therapy for Kidney Transplantation

M. Okumura, K. Ishiyama, S. Ashimine, Y. Miwa, K. Iwasaki, T. Kobayashi

Division of Kidney Transplantation, Department of Surgery, Aichi Medical University, Nagakute, Japan

Meeting: 2022 American Transplant Congress

Abstract number: 1668

Keywords: Immunosuppression, Pharmacokinetics

Topic: Clinical Science » Pharmacy » 30 - Non-Organ Specific: Clinical Pharmacy/Transplant Pharmacotherapy

Session Information

Session Name: Pharmacy II

Session Type: Poster Abstract

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: In recent years, significant improvement in organ transplant outcomes have been achieved by using multidrug therapy with several immune monitoring, but the complexity of assessing each drug interactions, including drug blood concentrations, has become a clinical problem. Area Under the Curve (AUC), one of the pharmacokinetic (PK) parameters, is an useful marker of bioavailability in determining the dosage of immunosuppressants. However, due to operational, financial, and patient burden, it is difficult to perform therapeutic drug monitoring for all patients as a practical matter.

*Methods: To evaluate the validity of AUC in optimizing the dose of immunosuppressants, we conducted a retrospective observational study of 204 living donor kidney transplants performed at our institution between July 2012 and October 2020, using the clinical course as an index. In the PK study conducted in the early postoperative period (1 month) and in the maintenance period (after 3 months) at our hospital, and we examined the correlation between AUC and C0, C1, and C2 of CNI (CSA, TAC), MMF, and EVR, respectively, and their association with clinical events.

*Results: Although there was a strong correlation between C2 and AUC of CSA and TAC (r=0.82 and 0.83 in early period: r=0.79 and 0.89 in maintenance period, respectively), there was no correlation between C0 and AUC (r=0.45 and 0.26 in early period: r=0.39 and 0.58 in maintenance period, respectively), indicating that maintenance of CNI by C0 alone is insufficient to control immunosuppressants. On the other hand, no correlation between C0, C1, and C2 and AUC was observed for MMF monitoring in both the early postoperative and maintenance phases (r=all less than 0.6), suggesting that adjusting MMF by AUC is essential for proper management. In the clinical course of the 156 patients who could be followed, de novo DSA was produced in 25 patients in spite of appropriate AUC control by PK study. Furthermore, there were 37 cases of post-transplant infections requiring hospitalization were observed, and bacterial urinary tract infections were the most prevalent. In patients with post-transplant infections, the group with high AUC despite low C0 in MMF, bacterial infections were found in 9 of 13 patients (69.2%) and viral infections in 16 of 35 patients (45.7%). This result suggested the importance of AUC measurement because only C0 control may result in over-immunosuppression in MMF control.

*Conclusions: This study revealed that AUC measurement is useful due to the effects of drug malabsorption and delayed absorption, and that it is important to perform PK analysis for CNI as well as MMF periodically for appropriate management of immunosuppressants.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Okumura M, Ishiyama K, Ashimine S, Miwa Y, Iwasaki K, Kobayashi T. Effectiveness and Limitations of PK Analysis in Optimization of Immunosuppressive Therapy for Kidney Transplantation [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/effectiveness-and-limitations-of-pk-analysis-in-optimization-of-immunosuppressive-therapy-for-kidney-transplantation/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences